Katz Barrett's Form 4 filing
Viridian Therapeutics, Inc. (VRDN) · filed Jan 11, 2023
- Accession no.
- 0000899243-23-001626
- Filed
- Jan 11, 2023
- Trade date
- Jan 9-10, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.09M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Katz BarrettCIK 0001841628 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 9, 2023 | Common Stock | MOption exerciseAcquired | +12,623 | $23.03 | +$290,707.69 | 12,623 | Direct | |
| Jan 9, 2023 | Common Stock | SSaleDisposed | −12,623 | $33.04 | −$417,063.92 | 0 | Direct | |
| Jan 10, 2023 | Common Stock | MOption exerciseAcquired | +47,377 | $23.03 | +$1,091,092.31 | 47,377 | Direct | |
| Jan 10, 2023 | Common Stock | SSaleDisposed | −47,377 | $35.30 | −$1,672,408.1 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 9, 2023 | Common Stock | MOption exerciseDisposed | −12,623 | $0.00 | $0 | 343,377 | Direct | |
| Jan 10, 2023 | Common Stock | MOption exerciseDisposed | −47,377 | $0.00 | $0 | 296,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.